Capitolis Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Capitolis Advisors LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$472.8 - $558.54 $2.1 Million - $2.48 Million
-4,448 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$446.73 - $548.2 $734,424 - $901,240
-1,644 Reduced 26.99%
4,448 $2.11 Million
Q4 2020

May 07, 2021
BUY
$478.3 - $607.98 $2.91 Million - $3.7 Million
6,092 New
6,092 $2.94 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capitolis Advisors LLC Portfolio

Follow Capitolis Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capitolis Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capitolis Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email